High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875

游离脂肪酸受体1 胰高血糖素样肽1受体 游离脂肪酸受体 部分激动剂 受体 兴奋剂 G蛋白偶联受体 变构调节 化学 生物物理学 生物化学 脂肪酸 生物 多不饱和脂肪酸
作者
Ankita Srivastava,Jason K. Yano,Yoshihiko Hirozane,Georgia Kefala,Franz Gruswitz,G. Snell,Weston Lane,Anthony Ivetac,Kathleen Aertgeerts,Jasmine Nguyen,Andy J. Jennings,Kengo Okada
出处
期刊:Nature [Nature Portfolio]
卷期号:513 (7516): 124-127 被引量:368
标识
DOI:10.1038/nature13494
摘要

The X-ray crystal structure of human GPR40 receptor in the presence of TAK-875, an orally available, potent and selective human GPR40 agonist. The G-protein-coupled receptor (GPCR) human GPR40 (hGPR40, also known as free fatty-acid receptor 1) is an attractive therapeutic target for the treatment of type-2 diabetes mellitus. It is a membrane protein expressed primarily in pancreatic β-cells and intestinal enteroendocrine cells and it acts as a nutrient sensor, enhancing insulin secretion and glucagon-like-peptide 1 secretion. This study reports the atomic details of hGPR40 in complex with TAK-875 (fasiglifam), a partial GPR40 agonist currently in phase III clinical trials. The structure reveals that TAK-875 binds in an usual way, and suggests that that TAK-875 and natural substrates enter the receptor binding pocket through the lipid bilayer. Human GPR40 receptor (hGPR40), also known as free fatty-acid receptor 1 (FFAR1), is a G-protein-coupled receptor that binds long-chain free fatty acids to enhance glucose-dependent insulin secretion1. Novel treatments for type-2 diabetes mellitus2 are therefore possible by targeting hGPR40 with partial or full agonists. TAK-875, or fasiglifam, is an orally available, potent and selective partial agonist3 of hGPR40 receptor, which reached phase III clinical trials for the potential treatment of type-2 diabetes mellitus4. Data from clinical studies indicate that TAK-875, which is an ago-allosteric modulator of hGPR40 (ref. 3), demonstrates improved glycaemic control and low hypoglycaemic risk in diabetic patients5. Here we report the crystal structure of hGPR40 receptor bound to TAK-875 at 2.3 A resolution. The co-complex structure reveals a unique binding mode of TAK-875 and suggests that entry to the non-canonical binding pocket most probably occurs via the lipid bilayer. The atomic details of the extensive charge network in the ligand binding pocket reveal additional interactions not identified in previous studies and contribute to a clear understanding of TAK-875 binding to the receptor. The hGPR40–TAK-875 structure also provides insights into the plausible binding of multiple ligands to the receptor, which has been observed in radioligand binding6 and Ca2+ influx assay studies3. Comparison of the transmembrane helix architecture with other G-protein-coupled receptors suggests that the crystallized TAK-875-bound hGPR40 complex is in an inactive-like state.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
叶艳完成签到 ,获得积分10
1秒前
拼搏曲奇完成签到,获得积分10
2秒前
姜太公发布了新的文献求助10
3秒前
3秒前
3秒前
大酱踢腿发布了新的文献求助10
3秒前
shocwk发布了新的文献求助10
4秒前
lyl发布了新的文献求助30
5秒前
Owen的应助被天天采纳,获得10
5秒前
小蘑菇的应助被天天采纳,获得10
5秒前
传奇3的应助被天天采纳,获得10
5秒前
Jasper的应助被积极的含灵采纳,获得10
5秒前
CodeCraft的应助被天天采纳,获得10
5秒前
可爱的函函的应助被天天采纳,获得10
5秒前
fangmeiyuan完成签到,获得积分10
6秒前
斯文败类的应助被天天采纳,获得10
6秒前
李爱国的应助被天天采纳,获得10
6秒前
天天快乐的应助被天天采纳,获得10
6秒前
完美世界的应助被天天采纳,获得10
6秒前
JamesPei的应助被天天采纳,获得10
6秒前
zhi完成签到,获得积分10
8秒前
carrot完成签到,获得积分10
9秒前
刘刘发布了新的文献求助10
10秒前
nunl发布了新的文献求助10
10秒前
岳雨萌完成签到,获得积分20
10秒前
墨雪归青完成签到,获得积分10
11秒前
金常常完成签到,获得积分10
12秒前
12秒前
momo完成签到 ,获得积分10
15秒前
15秒前
烟花的应助被zzz采纳,获得10
16秒前
NexusExplorer的应助被费洛蒙漩涡采纳,获得10
16秒前
沉静俊驰完成签到,获得积分10
17秒前
18秒前
奋斗者完成签到,获得积分10
18秒前
19秒前
打打的应助被科研通管家采纳,获得10
20秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
20秒前
共享精神的应助被科研通管家采纳,获得10
20秒前
我是老大的应助被ff采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191314
求助须知:如何正确求助?哪些是违规求助? 9578210
关于积分的说明 21857267
捐赠科研通 7790624
什么是DOI,文献DOI怎么找? 3436606
关于科研通互助平台的介绍 2560359
邀请新用户注册赠送积分活动 2483305